Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zandu Shareholders Choose Emami Group Over Parikh Family

This article was originally published in PharmAsia News

Executive Summary

Shareholders of India's Zandu Pharmaceuticals split with the controlling Parikh family and voted to sell their shares to a family rival, the Emami group that holds 24 percent of firm. The head of the stockholder group said shareholders feel the Emami should have had a role in the management the Parikh family controls. He said that with Emami involved in Zandu's operation, the shareholders would see a greater value for their stock, which the current management failed to provide. Zandu has not launched a significant new product for the past five years. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts